Medicine Overview of Evalin 5mg Tablet
- Short term anxiety
- Alcohol withdrawal
- Muscle spasm
- Epilepsy
- Fatigue
- Impaired coordination
- Drowsiness
- Muscle weakness
-
Evalin helps treat short term anxiety.
-
Safety of this medicine is not established for long-term use. Do not use it for more than 4 weeks.
-
The addiction / habit-forming potential of this medicine is very high. Take it only as per the dose and duration advised by your doctor
-
It may cause dizziness. Do not drive or do anything that requires mental focus until you know how this medicine affects you.
-
Avoid consuming alcohol as it may increase dizziness and drowsiness.
-
Inform your doctor if you are pregnant, planning to conceive or breastfeeding.
-
Do not stop taking medication suddenly without talking to your doctor as that may lead to nausea, anxiety, agitation, flu-like symptoms, sweating, tremor, and confusion.
IV Preparation
Compatibility with D5W, NS, and Ringer’s controversial. If infusion is selected, adding the infusion solution to the diazepam injection (and not the other way around) may prevent precipitate formation
IV Administration
Administer over 3 min; no more than 5 mg/min
Monitor respiration q5-15min and before each IV dose
Have airway support ready until effects of IV administration are known
Rectal Administration
Place patient on side facing you with upper leg bent forward, lubricate rectal applicator tip, gently insert syringe tip in rectum and slowly push plunger
Atax (3%),Euphoria (3%, rectal gel),Incoordination (3%, rectal gel),Somnolence (>1%),Rash (3%, rectal gel),Diarrhea (4%, rectal gel)
Frequency Not Defined
Common,Hypotension,Fatigue,Muscle weakness,Respiratory depression,Urinary retention,Depression,Incontinence,Blurred vision,Dysarthria,Headache,Skin rash,Changes in salivation,Serious,Neutropenia,Jaundice
Local effects: Pain, swelling, thrombophlebitis, carpal tunnel syndrome, tissue necrosis,Phlebitis if too rapid IV push
Potentially Fatal: Respiratory and CNS depression, coma.
Lactation: Enters breast milk; not recommended
Minor tranquilizers should be avoided in first trimester of pregnancy due to increased risk of congenital malformations
Maternal use shortly before delivery is associated with floppy infant syndrome (good and consistent evidence)
Prenatal benzodiazepine exposure slightly increased oral cleft risk (limited or inconsistent evidence)
May increase clearance w/ antibacterials which are known inducers of hepatic enzymes (e.g. rifampicin). May increase serum level w/ disulfiram. May reduce clearance of digoxin. May reduce therapeutic effect w/ theophylline. Reversible deterioration of parkinsonism w/ levodopa.

Reviews
Clear filtersThere are no reviews yet.